Modelling optimal vaccination strategies against COVID-19 in a context of Gamma variant predominance in BrazilArticle Published on 2022-11-022022-11-16 Journal: Vaccine [Category] COVID19(2023년), SARS, 변종, [키워드] accompanied age AZD1222 Brazil circulating variant Coverage COVID-19 death deaths dose driven by Effectiveness Epidemic estimates evaluate evaluated Evidence Gamma group groups Guidance health system immunization immunization strategy implementation increase in inefficient initial International interval Local modelling Older age outcome populations reached reducing required subsequent Support vaccination Vaccination strategy Vaccine vaccine availability Vaccines variant variants of concern VoC [DOI] 10.1016/j.vaccine.2022.09.082 PMC 바로가기
Longitudinal Serological Surveillance for COVID-19 Antibodies after Infection and VaccinationArticle Published on 2022-10-262022-11-15 Journal: Microbiology Spectrum [Category] 진단, [키워드] Ad26.COV2.S vaccine addition analyzed Anti-spike anti-spike antibody antibody Antibody titer association booster vaccination booster vaccinations Breakthrough infection breakthrough infections can be used Characteristics Cohort Complete conducted Confirmed COVID-19 infection COVID-19 COVID-19 infection COVID-19 infections COVID-19 pandemic Defense evaluate event events exhibited Health care system immunization include Infection infection risk infections Infectious disease information longitudinal mRNA mRNA vaccines occurred participant positively correlated Prevalence receive receiving reported Research risk significantly social distancing subject subjects the timing threshold vaccinated individuals vaccination vaccination responses Vaccination strategy vaccinee vaccinees [DOI] 10.1128/spectrum.02026-22 PMC 바로가기
Comparable diagnostic accuracy of SARS-CoV-2 Spike RBD and N-specific IgG tests to determine pre-vaccination nation-wide baseline seroprevalence in MexicoArticle Published on 2022-10-262022-11-15 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] Accuracy anti-nucleoprotein anti-RBD antibody marker baseline commercial immunoassay comparable country COVID-19 pandemic determine diagnostic Disease progression ELISA protocol Epidemic epidemiological heterogeneity IgG IgG test implementation Local marker natural infection positive post-symptom onset pre-vaccination Prevalence protocol RBD SARS-CoV-2 SARS-CoV-2 spike protein serological serological survey significantly spike vaccination Vaccination strategy [DOI] 10.1038/s41598-022-22146-8 PMC 바로가기
Self-collection of capillary blood and saliva to determine COVID-19 vaccine immunogenicity in patients with immune-mediated inflammatory diseases and health professionalsArticle Published on 2022-10-142022-11-15 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 진단, [키워드] Accuracy analyzed antibodies Antibody Response being Blood blood collection both group capillary capillary blood Clinical practice collected correlation coefficient COVID-19 COVID-19 vaccine criteria determine dose effective evaluate feasibility feasible flexible Health Immune-mediated inflammatory disease less majority NPs participant Patient patient groups professional promoter protocol recorded Remote care reported Safe Saliva SARS-CoV-2 antibody response SARS-CoV-2 vaccines self-collection Self-sampling significantly significantly higher Spearman SUS telehealth Usability vaccination Vaccination strategy Vaccine venous Wilcoxon signed-rank test [DOI] 10.3389/fpubh.2022.994770 PMC 바로가기
Comparative Analysis of Antibody Titers against the Spike Protein of SARS-CoV-2 Variants in Infected Patient Cohorts and Diverse Vaccination RegimesArticle Published on 2022-10-132022-11-15 Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] accompanied antibody Antibody Response AstraZeneca B cell benefit booster vaccination cells Comparative courses COVID-19 COVID-19 pandemic Critical critical COVID-19 patients exceeded follicular Frequency Infection Inflammation Inflammatory response Johnson & Johnson long-COVID Lymphocytes Mild Moderna mRNA vaccine neutralizing antibody patients patients who survived Pfizer-BioNTech recommendation reduced regime SARS-CoV-2 SARS-CoV-2 patient severe COVID-19 disease the SARS-CoV-2 virus the Spike titer understanding vaccination Vaccination strategy Vaccine [DOI] 10.3390/ijms232012231 PMC 바로가기
Timing of SARS-CoV-2 Vaccination Matters in People With Multiple Sclerosis on Pulsed Anti-CD20 TreatmentArticle Published on 2022-10-122022-11-15 Journal: Neurology® neuroimmunology & neuroinflammation [Category] COVID19(2023년), SARS, 바이오마커, 변종, 진단, [키워드] acute respiratory syndrome Analysis analyzed anti-SARS-CoV-2 antibody Antibody Response association Blood CD19 CD3 CD4 CD8 CD8 T cell CD8 T-cell response cellular center clinical decision Cohort collected conducted coronavirus coronavirus disease correlated cross-sectional Defense evaluate Germany humoral immune response Humoral response immune response Immunoglobulin Infection interferon-γ interval lymphocyte counts matter Multiple multiple sclerosis Patient peptide pools receiving regulated response responses Sample SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike SARS-CoV-2 vaccination sclerosis significantly increased Spike protein Status post subpopulation T cell T-cell the timing Treatment vaccination vaccination response Vaccination strategy variants of concern were measured [DOI] 10.1212/NXI.0000000000200031 PMC 바로가기
Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccinesArticle Published on 2022-10-042022-11-15 Journal: PLoS Pathogens [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] Activation antibody Antibody Response Antibody titre antigen exposure baseline benefit binding BNT162b2 boost CD4+ T cell CD8+ Cellular immune response clinical trial Course COVID-19 Delta dose ELISA ELISPOT enhanced global public health glycoprotein Heterologous highest humoral immune memory immune response immunological increase in individual majority marker median mRNA mRNA COVID-19 vaccine mRNA vaccination mRNA vaccine naïve natural infection neutralising antibody titre omicron participant Participants PCR proportion question receiving recruited response RNA SARS-CoV-2 vaccine second dose seroconverted significantly higher subject the SARS-CoV-2 titre vaccination Vaccination strategy Vaccine variants were measured wildtype [DOI] 10.1371/journal.ppat.1010885 PMC 바로가기
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concernArticle Published on 2022-10-032022-11-15 Journal: PLoS Pathogens [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] BNT162b2 booster breadth Breakthrough infection Coverage COVID-19 COVID-19 pandemic COVID-19 vaccine ENhance extended interval generate identify immune response immune responses immunogen individual Lineage magnitude memory B cells Mutation neutralization activity neutralization breadth Neutralizing antibody response of BNT162b2 omicron Population proportion reactive receiving regimen SARS-CoV-2 variant second dose spike Surface glycoprotein two groups vaccination Vaccination strategy Vaccine vaccine dose [DOI] 10.1371/journal.ppat.1010882 PMC 바로가기
Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach With External ValidationArticle Published on 2022-10-012022-11-15 Journal: Transplantation [Category] COVID19(2023년), SARS, 진단, [키워드] Antibody Response Antibody testing association BNT162b2 calculator characteristic clinical factor clinical factors Cohort contributing to dose External external validation facilitate Follow-up help Houston identify immunosuppressants less machine learning moderate mRNA mRNA vaccines mRNA-1273 mycophenolate mofetil negative antibody response Older age organ Other Patient Precision predictor protective immunity recipient recommendations response risk factor risk stratification SARS-CoV-2 Sex solid organ Transplant understanding Vaccination strategy Vaccine vaccine dose vaccine response validation was performed [DOI] 10.1097/TP.0000000000004259 PMC 바로가기
Impaired serological response to COVID-19 vaccination following anticancer therapy: A systematic review and meta-analysis항암 치료 후 코로나19 백신 접종에 따른 혈청학적 반응 저하: 체계적 고찰 및 메타분석Meta-Analysis Published on 2022-10-012022-09-12 Journal: Journal of medical virology [Category] Fulltext, MERS, 진단, [키워드] 95% confidence interval Affect anti-CD20 antibody anticancer association B-cell lymphoma Cancer cellular response Chemotherapy conducted coronavirus disease correlated COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines demonstrated dose evaluate Fatality rate hormonal therapy humoral immune response Immunotherapy Impaired inhibitor Meta-analysis morbidity Odds ratio Patient patients Patients with cancer postvaccination Research response to vaccination risk Seroconversion seroconversion rate serological serological response significantly significantly lower subgroup analysis suggested systematic review targeted therapy therapy Treatment tyrosine vaccination Vaccination strategy Vaccine [DOI] 10.1002/jmv.27956 PMC 바로가기 [Article Type] Meta-Analysis